149 related articles for article (PubMed ID: 24347984)
41. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
[TBL] [Abstract][Full Text] [Related]
42. Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study.
Ruggiero S; Rafaniello C; Bravaccio C; Grimaldi G; Granato R; Pascotto A; Sportiello L; Parretta E; Rinaldi B; Panei P; Rossi F; Capuano A
J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):415-22. PubMed ID: 23234585
[TBL] [Abstract][Full Text] [Related]
43. Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
Giezen TJ; Mantel-Teeuwisse AK; Meyboom RH; Straus SM; Leufkens HG; Egberts TC
Drug Saf; 2010 Oct; 33(10):865-78. PubMed ID: 20812771
[TBL] [Abstract][Full Text] [Related]
44. The Importance of Direct Patient Reporting of Adverse Drug Reactions in the Safety Monitoring Process.
Sienkiewicz K; Burzyńska M; Rydlewska-Liszkowska I; Sienkiewicz J; Gaszyńska E
Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010673
[TBL] [Abstract][Full Text] [Related]
45. Analysis of spontaneous reporting of suspected adverse drug reactions for non-analgesic over-the-counter drugs from 2008 to 2017.
Bukic J; Rusic D; Mas P; Karabatic D; Bozic J; Seselja Perisin A; Leskur D; Krnic D; Tomic S; Modun D
BMC Pharmacol Toxicol; 2019 Oct; 20(1):60. PubMed ID: 31627740
[TBL] [Abstract][Full Text] [Related]
46. Neurologists' Knowledge, Practice, and Attitudes towards Pharmacovigilance and Adverse Drug Reactions Reporting Process in Epileptic Patients-Comparative Analysis from Poland and Egypt.
Kopciuch D; Kamal NN; Kamal NN; Hamdy NA; Paczkowska A; Zaprutko T; Ratajczak P; Fliciński J; Kus K; Nowakowska E
Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409851
[TBL] [Abstract][Full Text] [Related]
47. Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data.
Dipasquale V; Cicala G; Laganà F; Cutroneo P; Felicetti P; Potenza S; Trimarchi G; Spina E; Romano C
Expert Opin Drug Saf; 2022 Jan; 21(1):127-132. PubMed ID: 34494498
[TBL] [Abstract][Full Text] [Related]
48. Pharmacovigilance knowledge in family paediatricians. A survey study in Italy.
Pellegrino P; Carnovale C; Cattaneo D; Perrone V; Antoniazzi S; Pozzi M; Napoleone E; Filograna MR; Clementi E; Radice S
Health Policy; 2013 Nov; 113(1-2):216-20. PubMed ID: 24012386
[TBL] [Abstract][Full Text] [Related]
49. Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy.
Salvo F; Polimeni G; Moretti U; Conforti A; Leone R; Leoni O; Motola D; Dusi G; Caputi AP
J Antimicrob Chemother; 2007 Jul; 60(1):121-6. PubMed ID: 17449881
[TBL] [Abstract][Full Text] [Related]
50. Knowledge, attitude and practice of physicians and nurses at the cape coast teaching hospital in the Central Region of Ghana on spontaneous adverse drug reaction reporting.
Powell JF; Henneh IT; Ekor M
PLoS One; 2023; 18(7):e0288100. PubMed ID: 37418384
[TBL] [Abstract][Full Text] [Related]
51. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
[TBL] [Abstract][Full Text] [Related]
52. A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016.
Ogar CK; Abiola A; Yuah D; Ibrahim A; Oreagba IA; Amadi EC; Adeyeye MC; Oshikoya KA
Pharmaceut Med; 2019 Apr; 33(2):145-157. PubMed ID: 31933250
[TBL] [Abstract][Full Text] [Related]
53. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012.
Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I
Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567
[TBL] [Abstract][Full Text] [Related]
54. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year.
Singh P; Agrawal M; Hishikar R; Joshi U; Maheshwari B; Halwai A
Indian J Pharmacol; 2017; 49(6):432-437. PubMed ID: 29674797
[TBL] [Abstract][Full Text] [Related]
55. Pharmacovigilance in healthcare education: students' knowledge, attitude and perception: a cross-sectional study in Saudi Arabia.
Alwhaibi M; Alhindi G; Alshamrani M; Essa MB; A Al Aloola N; Alhawassi TM
BMC Med Educ; 2020 Jul; 20(1):210. PubMed ID: 32616054
[TBL] [Abstract][Full Text] [Related]
56. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
[TBL] [Abstract][Full Text] [Related]
57. Suspected adverse drug reactions (ADRs) trends in older Italian patients: an analysis from the National Pharmacovigilance Network.
Sferrazza G; Nicotera G; Pierimarchi P
Aging Clin Exp Res; 2021 Jun; 33(6):1683-1687. PubMed ID: 31429004
[TBL] [Abstract][Full Text] [Related]
58. Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system.
Rafaniello C; Ferrajolo C; Sullo MG; Sessa M; Sportiello L; Balzano A; Manguso F; Aiezza ML; Rossi F; Scarpignato C; Capuano A
Pharmacol Res; 2016 Feb; 104():108-14. PubMed ID: 26739516
[TBL] [Abstract][Full Text] [Related]
59. Surveillance of Drug Safety During Pregnancy: Insight in Current International Activities, Future Intentions and Need for Support of National Pharmacovigilance Centres.
Kant A; de Vries L; Rolfes L
Drug Saf; 2019 Jan; 42(1):35-43. PubMed ID: 30284215
[TBL] [Abstract][Full Text] [Related]
60. Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system.
Sessa M; Bernardi FF; Vitale A; Schiavone B; Gritti G; Mascolo A; Bertini M; Scavone C; Sportiello L; Rossi F; Capuano A
J Clin Pharm Ther; 2018 Dec; 43(6):867-876. PubMed ID: 30014479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
